NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.
NACDS is urging support for a bipartisan Senate letter to Health and Human Services Secretary Alex Azar on DIR fee reform.
NACDS attended a conference this week hosted by Rep. Markwayne Mullin (R-OK) lauding the passage of new opioid legislation.
Lawmakers back in their congressional districts while Congress is on recess got to see the valuable services pharmacists provide to their constituents every day.
NACDS applauded the Trump Administration’s focus on reducing patients’ out-of-pocket drug costs, and Congressional sponsors’ effectiveness in advancing the "gag clause" ban. NACDS noted that pharmacy is a long-standing and trusted partner in helping patients achieve prescription-drug affordability – which is essential for health and wellness.
Legislation headed to President’s desk bears pharmacists’ insights from front lines of care, reflects pharmacy’s commitment as part of the solution to abuse.
NACDS is lauding Congress’ decisions on e-prescribing, initial fills, drug disposal, PDMPs – and enhanced MTM eligibility.
The legislation will prevent restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance. Meanwhile, NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs.
The House and Senate now must arrive at final version of broader opioid-abuse-prevention legislation. Meanwhile, state legislatures and executive branches are taking action to advance electronic prescribing as well.
House Energy & Commerce Committee Vice Chairman Joe Barton (R-TX) toured an Albertson’s pharmacy in Arlington, Tex., as part of the NACDS RxIMPACT advocacy program.